“Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”, J of Skin, vol. 6, no. 2, pp. 109–121, Mar. 2022, doi: 10.25251/skin.6.2.4.